Pharmaceutical Intermediates Market Current and Future Trends, Leading Players, Industry Segments and Regional Forecast By 2022-2030 | Says FMI Analyst
The rapidly increasing prevalence of chronic diseases around
the world is expected to fuel the need for novel drugs and better treatment
option would further drive the growth of the global market. Due to increasing
demand for novel drugs option, there has been rising applications of drug
intermediates and growing adoption and in the field of research and clinical
studies.
Leading players in the biotechnology and pharmaceutical
sectors along with research institutes are now increasingly focusing on R&D
activities relating to drug creation and development. Future Market Insights
(FMI) in a new study has forecast the global pharmaceutical intermediates to
reach US$ 30 Bn in 2020, with the market predicted to exhibit a CAGR of 4%
during the forecast period (2020-2030)
Click to get the
Sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-4515
Pharmaceutical intermediates are used in during
manufacturing of bulk drugs as raw materials. These are the material produced
during the synthesis of an active pharmaceutical ingredient (API). However,
pharmaceutical and biotech companies can make use of these drug intermediates
for the purposes of research and development (R&D). Moreover, there are
different forms of pharmaceutical intermediates available such as high quality
pharmaceutical intermediates, moderate quality pharmaceutical intermediates and
premium quality intermediates. The high-quality and premium pharmaceutical
intermediates are mainly used for R&D activities.
COVID-19 pandemic is negatively impacting pharmaceutical
intermediates sales due to supply chain disruptions caused due to extended
period of lockdown. Nonetheless growth is expected to recover because an
increasing number of pharma companies are engaging in research and development
to find effective treatment and vaccination for COVID-19 virus.
Key Takeaways from Pharmaceutical Intermediates Marker
Study
- The
demand for chiral intermediates will continue rising through the forecast
period
- East
Asia will dominate in the global pharmaceutical
intermediates market. China is expected to emerge as the most
lucrative market for pharmaceutical intermediates in the region.
- Analgesics
to remain primary application, expanding at Y-o-Y rate exceeding 6%
through 2020
- The
demand for Generic Drug Intermediates is expected to be higher than
Branded Drug Intermediates
- Biotech
and Pharma Companies will continue exhibiting high demand for
pharmaceutical intermediates
“Rising drug development activities worldwide as well as
increasing adaption of pharmaceutical intermediates as raw material are driving
the growth of global Pharmaceutical Intermediates market” says the FMI Analyst
Acquisitions, Partnerships and expansion are key
Strategic Focus of Pharmaceutical Intermediates Market Players
Leading players in the Pharmaceutical Intermediates market
on strengthening their market position though the Acquisition, Partnerships and
expansion. For Instance,
- On
April 2018, strategic collaboration between Porton Pharma Solutions, Ltd.
And Codexis, Inc. to use Codexis’ biocatalyst technology within Porton’s
global custom active pharmaceutical ingredients (API) and intermediate for
manufacturing business.
- On
June 2017, BASF SE is expanding its production capacity at Texas site,
whereas it is also constructing new Ibuprofen API facility in
Ludwigshafen, Germany, which is expected to be functional in 2021.
Key Participant Insights
The global market is set to expand its scope in the forecast
period, due to rising prevalence of chronic disease globally and adoption of
Pharmaceutical Intermediates at various stages of drug development by
pharmaceutical manufacturers. In addition to this, cost effectiveness and rise
in alternate methods for purification of oligonucleotide has augmented the
sales of Pharmaceutical Intermediates.
The key market players covered by FMI include Chiracon GmbH,
Aceto Corporation, Midas Pharma GmbH, Codexis, Lianhe Chemical Technology Co.,
Ltd, Sanofi S.A, Dishman Group And BASF SE, And Chemcon Speciality Chemicals
Pvt. Ltd consolidating their positions through mergers, acquisitions and new
product launches.
Click to get the TOC of this Report with figures: https://www.futuremarketinsights.com/reports/pharmaceutical-intermediates-market/table-of-content
About the Healthcare Division at Future Market Insights
Future Market Insights facilitates corporates, government,
investors, and associated audiences in the healthcare sector
to identify and accentuate vital aspects applicable to product strategy,
regulatory landscape, technology evolution, and other crucial issues to achieve
sustainable success. Our unique approach to gathering market intelligence
equips you in devising innovation-driven trajectories for your business. Know
more about our sector coverage here
About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and
consulting services, serving clients in over 150 countries. FMI is
headquartered in Dubai, and has delivery centers in the UK, U.S. and India.
FMI’s latest market research reports and industry analysis help
businesses navigate challenges and make critical decisions with confidence and
clarity amidst breakneck competition. Our customized and syndicated market
research reports deliver actionable insights that drive sustainable
growth. A team of expert-led analysts at FMI continuously tracks emerging
trends and events in a broad range of industries to ensure that our clients
prepare for the evolving needs of their consumers.
Contact Us:
Future Market Insights
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
Comments
Post a Comment